Examkin

Question

Difficulty: HardEndocrinology and Metabolism

During a multi-disciplinary endocrine case conference, several unique presentations of calcium and phosphorus dysregulation are discussed. Match each of the following distinct laboratory profiles with its corresponding underlying pathophysiologic mechanism. (Reference ranges: Calcium 8.4-10.2 mg/dL, Phosphorus 2.5-4.5 mg/dL, Intact PTH 10-65 pg/mL, 24-hr urine calcium 100-300 mg/day)

  • Profile 1: Calcium 11.2 mg/dL, Phosphorus 2.1 mg/dL, Intact PTH 115 pg/mL, 24-hr urine calcium 350 mgAutonomous parathyroid hormone overproduction
  • Profile 2: Calcium 11.4 mg/dL, Phosphorus 3.2 mg/dL, Intact PTH 55 pg/mL, 24-hr urine calcium 45 mgInactivating mutation of the calcium-sensing receptor
  • Profile 3: Calcium 11.8 mg/dL, Phosphorus 4.9 mg/dL, Intact PTH 9 pg/mL, 1,25-dihydroxyvitamin D 95 pg/mL (High)Pathologic extrarenal 1-alpha-hydroxylase activity
  • Profile 4: Calcium 7.2 mg/dL, Phosphorus 5.8 mg/dL, Intact PTH 180 pg/mL, Creatinine 0.8 mg/dLEnd-organ resistance to parathyroid hormone

Answer

Profile 1 maps to autonomous parathyroid hormone overproduction. Profile 2 maps to inactivating mutation of the calcium-sensing receptor. Profile 3 maps to pathologic extrarenal 1-alpha-hydroxylase activity. Profile 4 maps to end-organ resistance to parathyroid hormone.
Each laboratory profile distinctly maps to a unique disturbance in calcium-phosphorus homeostasis based on physiological feedback loops. Profile 1 shows autonomous PTH action (calcium up, phos down, urine calcium high). Profile 2 shows an altered set-point for calcium sensing (calcium up, phos normal, urine calcium uniquely low). Profile 3 shows PTH-independent hypercalcemia driven by ectopic Vitamin D (calcium up, phos up, PTH down). Profile 4 shows failure of PTH at target tissues (calcium down, phos up, PTH sky-high despite normal kidney function).

Step-by-Step Solution

1
Analyze Profile 1 for primary derangement
Identified hypercalcemia, hypophosphatemia, and hypercalciuria with inappropriately elevated PTH.
This pattern is classic for primary hyperparathyroidism, where an autonomous source (like an adenoma) secretes PTH independently of negative feedback.
2
Analyze Profile 2 for distinguishing features from Profile 1
Identified hypercalcemia with unsuppressed PTH but very low 24-hour urine calcium.
Hypocalciuria differentiates familial hypocalciuric hypercalcemia (FHH) from primary hyperparathyroidism. FHH requires higher serum calcium to suppress PTH and excrete calcium due to a mutant receptor.
3
Analyze Profile 3 for PTH-independent hypercalcemia
Identified hypercalcemia and hyperphosphatemia with properly suppressed PTH and elevated active Vitamin D.
Ectopic 1-alpha-hydroxylase activity (e.g., in sarcoidosis) creates excess active Vitamin D, which increases GI absorption of both calcium and phosphorus, subsequently suppressing endogenous PTH.
4
Analyze Profile 4 for cause of hypocalcemia
Identified hypocalcemia and hyperphosphatemia despite extremely high PTH levels and normal renal function.
The kidneys are not responding to PTH (which would normally lower phosphate and raise calcium). This end-organ resistance is the defining feature of pseudohypoparathyroidism.

Key Concept

Differentiation of calcium homeostasis disorders requires integrating serum calcium, phosphorus, and PTH, along with adjunctive markers like 24-hour urinary calcium and Vitamin D levels.
Estimated Time:2m 0s
Rate this question

Topics

Endocrinology and Metabolism

More questions from this topic